title: Effect of oral and inhaled cetirizine in allergen induced bronchoconstriction.
abstract: Cetirizine is a potent, selective H1 histamine receptor antagonist. The effect of oral and inhaled cetirizine was assessed on the early bronchoconstrictor response to inhaled allergen in 10 mild atopic asthmatic patients in a double-blind, randomized, placebo controlled trial. All were sensitive to Dermatophagoides pteronyssinus and this was used as the provoking allergen. The geometric mean PD20 FEV1 values obtained at allergen challenge were measured as cumulative breath units (c.b.u.) and following oral cetirizine, inhaled cetirizine and placebo were 124.5, 75.7 and 76.7 c.b.u. respectively. These did not differ significantly. We conclude that neither oral nor inhaled cetirizine significantly attenuates the early response to inhaled allergen in atopic asthmatic subjects. However, the method of repeated allergen challenge is likely to be relatively insensitive.
authors.affiliation: Department of Respiratory Medicine, Western Infirmary, Glasgow, U.K.
authors.forename: P
authors.initials: P
authors.lastname: Rafferty
authors.forename: S K
authors.initials: SK
authors.lastname: Ghosh
authors.forename: C
authors.initials: C
authors.lastname: de Vos
authors.forename: K R
authors.initials: KR
authors.lastname: Patel
mesh_terms: D000280:Administration, Inhalation; D000284:Administration, Oral; D000328:Adult; D000485:Allergens / Q000276:immunology*; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D016084:Bronchoconstriction / Q000187:drug effects*; D017332:Cetirizine / Q000008:administration & dosage* / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D008297:Male
chemical_list: D000485:Allergens; D017332:Cetirizine